Progress of medical treatment of coronary heart disease
10.12092/j.issn.1009-2501.2022.04.008
- Author:
Shufu CHANG
1
Author Information
1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai Clinical Research Center for Interventional Medicine, National Clinical Research Center for Interventional Medicine
- Publication Type:Journal Article
- Keywords:
Antiplatelet;
Coronary heart disease;
Inflammation
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2022;27(4):405-408
- CountryChina
- Language:Chinese
-
Abstract:
Coronary heart disease (CHD) treatment methods are changing rapidly, and new drugs are constantly entering the clinic. Antiplatelet drugs are the basis for the treatment of CHD, but there are currently no new drugs that can challenge the status of aspirin and P2Y
